|
EP1339863A2
(en)
|
2000-12-05 |
2003-09-03 |
Wisconsin Alumni Research Foundation |
Double transposition methods for manipulating nucleic acids
|
|
US7064246B2
(en)
|
2001-05-01 |
2006-06-20 |
Macrae Amy F |
Use of transposable elements for altering gene expression
|
|
US7262056B2
(en)
|
2001-11-08 |
2007-08-28 |
Mirus Bio Corporation |
Enhancing intermolecular integration of nucleic acids using integrator complexes
|
|
EP1458875A2
(de)
|
2001-12-20 |
2004-09-22 |
Sungene GmbH & Co. KGaA |
Verfahren zur transformation von pflanzlichen plastiden
|
|
ATE498016T1
(de)
|
2003-02-10 |
2011-02-15 |
Max Delbrueck Centrum |
Transposon-system zur gezielten integration
|
|
DK1594973T3
(da)
|
2003-02-10 |
2012-02-13 |
Max Delbrueck Centrum |
Transposonbaseret målretningssystem
|
|
GB2403475B
(en)
|
2003-07-01 |
2008-02-06 |
Oxitec Ltd |
Stable integrands
|
|
WO2005062881A2
(en)
|
2003-12-24 |
2005-07-14 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
|
US20060252140A1
(en)
|
2005-04-29 |
2006-11-09 |
Yant Stephen R |
Development of a transposon system for site-specific DNA integration in mammalian cells
|
|
EP1921140B1
(en)
|
2005-07-05 |
2011-12-14 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Mutant transposon vector and use thereof
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
US8524979B2
(en)
|
2008-04-14 |
2013-09-03 |
National Taiwan University |
Termination of transgene expression via transposon-mediated break
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
WO2010099296A1
(en)
|
2009-02-26 |
2010-09-02 |
Transposagen Biopharmaceuticals, Inc. |
Hyperactive piggybac transposases
|
|
BRPI1010759B1
(pt)
|
2009-06-11 |
2019-07-16 |
Inter-University Research Institute Corporation Research Organization Of Information And Systems |
Método para produzir uma proteína de interesse ou para obter uma suspensão de células de mamíferos capaz de produzir uma proteína de interesse, bem como vetor de expressão de proteína
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US20130017978A1
(en)
|
2011-07-11 |
2013-01-17 |
Finnzymes Oy |
Methods and transposon nucleic acids for generating a dna library
|
|
WO2013040557A2
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
DK3141259T3
(da)
|
2012-03-15 |
2019-09-30 |
Cellectis |
Repeat-variable direster til targeting af nukleotider
|
|
ES2528892T3
(es)
|
2012-07-30 |
2015-02-13 |
Nbe-Therapeutics Llc |
Identificación mediada por trasposición de proteínas de unión o funcionales específicas
|
|
DK3536797T5
(da)
|
2013-02-01 |
2024-09-02 |
Selexis Sa |
Forhøjet transgenudtrykkelse og -forarbejdning
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2943296C
(en)
|
2014-03-21 |
2022-10-18 |
The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) |
Stable gene transfer to proliferating cells
|
|
CN103981204B
(zh)
|
2014-03-24 |
2016-05-04 |
上海海洋大学 |
一种有活性的金鱼Tgf2转座子重组转座酶蛋白的表达方法
|
|
US9534234B2
(en)
|
2014-04-09 |
2017-01-03 |
Dna2.0, Inc. |
Enhanced nucleic acid constructs for eukaryotic gene expression
|
|
EP3157328B1
(en)
|
2014-06-17 |
2021-08-04 |
Poseida Therapeutics, Inc. |
A method for directing proteins to specific loci in the genome and uses thereof
|
|
AU2015323973A1
(en)
|
2014-09-29 |
2017-04-20 |
The Jackson Laboratory |
High efficiency, high throughput generation of genetically modified mammals by electroporation
|
|
EP3018200A1
(en)
|
2014-11-07 |
2016-05-11 |
Fondazione Matilde Tettamanti e Menotti de Machi Onlus |
Improved method for the generation of genetically modified cells
|
|
KR20250171479A
(ko)
|
2015-03-31 |
2025-12-08 |
소흠, 인코포레이티드 |
세포 또는 유기체의 게놈으로의 ＤＮＡ 서열의 표적화 혼입을 위한 Ｃａｓ 9 레트로바이러스 인테그라제 시스템 및 Ｃａｓ 9 재조합효소 시스템
|
|
ES2926467T3
(es)
|
2015-04-13 |
2022-10-26 |
Maxcyte Inc |
Métodos y composiciones para la modificación del ADN genómico
|
|
US20180087050A1
(en)
|
2015-05-27 |
2018-03-29 |
Jianbiao Zheng |
Methods of inserting molecular barcodes
|
|
EP3929286A1
(en)
|
2015-06-17 |
2021-12-29 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
EP3350335B1
(en)
|
2015-09-16 |
2019-11-27 |
T-CURX GmbH |
Improved transposon system for gene delivery
|
|
EP4706680A3
(en)
|
2015-09-22 |
2026-03-25 |
Julius-Maximilians-Universität Würzburg |
A method for high level and stable gene transfer in lymphocytes
|
|
CN105154473B
(zh)
|
2015-09-30 |
2019-03-01 |
上海细胞治疗研究院 |
一种高效安全的转座子整合系统及其用途
|
|
EP4289944A3
(en)
|
2015-10-08 |
2024-03-13 |
National University Corporation Tokai National Higher Education and Research System |
Method for preparing genetically-modified t cells which express chimeric antigen receptor
|
|
JP6956416B2
(ja)
|
2015-12-14 |
2021-11-02 |
ゲノムフロンティア セラピューティクス，インコーポレイテッド |
トランスポゾン系、それを含むキット及びそれらの使用
|
|
US20190169602A1
(en)
|
2016-01-12 |
2019-06-06 |
Seqwell, Inc. |
Compositions and methods for sequencing nucleic acids
|
|
KR20190003938A
(ko)
|
2016-02-25 |
2019-01-10 |
셀 메디카 스위처란트 아게 |
면역치료를 위한 변형된 세포
|
|
CA3015642A1
(en)
|
2016-02-26 |
2017-08-31 |
Poseida Therapeutics, Inc. |
Transposon system and methods of use
|
|
EP3219800A1
(en)
|
2016-03-15 |
2017-09-20 |
Max-Delbrück-Centrum Für Molekulare Medizin |
A transposon-based transfection system for primary cells
|
|
CN118147079A
(zh)
|
2016-03-31 |
2024-06-07 |
来恩生物医药私人有限公司 |
表达外源病毒特异性t细胞受体(tcr)的非活化t细胞
|
|
CA3022267A1
(en)
|
2016-05-04 |
2017-11-09 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
CN114891751A
(zh)
|
2016-06-20 |
2022-08-12 |
上海细胞治疗研究院 |
一种高效稳定表达激活型抗体的car-t细胞及其用途
|
|
CN107523545A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的杀伤性细胞及其用途
|
|
CN107523548A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的t细胞及其用途
|
|
CN107523547A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
KR20190031306A
(ko)
|
2016-07-21 |
2019-03-25 |
맥스시티 인코포레이티드 |
게놈 dna를 변경하기 위한 방법 및 조성물
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
EP3508574B1
(en)
|
2016-08-30 |
2024-10-09 |
Kyushu University, National University Corporation |
Method for inserting desired dna fragment into site located adjacent to binding domain of dna-binding protein
|
|
WO2018057779A1
(en)
|
2016-09-23 |
2018-03-29 |
Jianbiao Zheng |
Compositions of synthetic transposons and methods of use thereof
|
|
SG11201901959YA
(en)
|
2016-09-30 |
2019-04-29 |
Poseida Therapeutics Inc |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
MA46959A
(fr)
|
2016-12-02 |
2019-10-09 |
Juno Therapeutics Inc |
Cellules b modifiées et compositions et méthodes associées
|
|
AU2017378482B2
(en)
*
|
2016-12-16 |
2024-06-13 |
R&D Systems, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
KR20190102259A
(ko)
|
2017-01-10 |
2019-09-03 |
인트렉손 코포레이션 |
신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절
|
|
WO2018140644A1
(en)
|
2017-01-25 |
2018-08-02 |
Musc Foundation For Research Development |
Modified t cells and uses thereof
|
|
AU2019288669B2
(en)
*
|
2018-06-21 |
2025-06-26 |
R&D Systems, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|